Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,390
Total Claims
$933K
Drug Cost
971
Beneficiaries
$961
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+30%
Opioid rate vs peers
59.6% vs 45.9% avg
+99%
Cost per patient vs peers
$961 vs $483 avg
+86%
Brand preference vs peers
7.7% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
59.6%
Opioid Rate
8,578
Opioid Claims
$676K
Opioid Cost
24.7%
Long-Acting Rate
This provider's opioid prescribing rate of 59.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,105 claims · $502K
Generic: 13,285 claims · $432K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine | 287 | $102K |
| Buprenorphine Hcl | 124 | $92K |
| Oxycodone Myristate | 117 | $86K |
| Hydrocodone/Acetaminophen | 2,807 | $81K |
| Oxycodone Hcl/Acetaminophen | 1,477 | $58K |
| Oxycodone Hcl | 114 | $58K |
| Buprenorphine | 53 | $35K |
| Tapentadol Hcl | 30 | $31K |
| Linaclotide | 45 | $27K |
| Fentanyl | 240 | $26K |
| Oxycodone Hcl | 998 | $24K |
| Naloxone Hcl | 277 | $24K |
| Suvorexant | 51 | $23K |
| Morphine Sulfate | 771 | $21K |
| Gabapentin | 1,166 | $21K |
Prescribing Profile
56
Unique Drugs
21.0
Anomaly Score
Patient Profile
66
Avg Age
62%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data